These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 16859431

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
    Anderson PM, Wiseman GA, Dispenzieri A, Arndt CA, Hartmann LC, Smithson WA, Mullan BP, Bruland OS.
    J Clin Oncol; 2002 Jan 01; 20(1):189-96. PubMed ID: 11773169
    [Abstract] [Full Text] [Related]

  • 4. Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases.
    Lam MG, Dahmane A, Stevens WH, van Rijk PP, de Klerk JM, Zonnenberg BA.
    Eur J Nucl Med Mol Imaging; 2008 Apr 01; 35(4):756-65. PubMed ID: 18157530
    [Abstract] [Full Text] [Related]

  • 5. A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases.
    Turner JH, Claringbold PG, Hetherington EL, Sorby P, Martindale AA.
    J Clin Oncol; 1989 Dec 01; 7(12):1926-31. PubMed ID: 2585026
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of bone pain secondary to metastases using samarium-153-EDTMP.
    Etchebehere EC, Pereira Neto CA, Lima MC, Santos Ade O, Ramos CD, Silva CM, Camargo EE.
    Sao Paulo Med J; 2004 Sep 02; 122(5):208-12. PubMed ID: 15558143
    [Abstract] [Full Text] [Related]

  • 9. Samarium 153Sm lexidronam.
    Lamb HM, Faulds D.
    Drugs Aging; 1997 Nov 02; 11(5):413-8; discussion 419. PubMed ID: 9359026
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Samarium-153-EDTMP biodistribution and dosimetry estimation.
    Eary JF, Collins C, Stabin M, Vernon C, Petersdorf S, Baker M, Hartnett S, Ferency S, Addison SJ, Appelbaum F.
    J Nucl Med; 1993 Jul 02; 34(7):1031-6. PubMed ID: 7686217
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Samarium-153-EDTMP in bone metastases.
    Ahonen A, Joensuu H, Hiltunen J, Hannelin M, Heikkilä J, Jakobsson M, Jurvelin J, Kairemo K, Kumpulainen E, Kulmala J.
    J Nucl Biol Med (1991); 1994 Dec 02; 38(4 Suppl 1):123-7. PubMed ID: 7543288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.